1. PET-based compartmental modeling of 124I-A33 antibody: quantitative characterization of patient-specific tumor targeting in colorectal cancer
    Pat Zanzonico et al, 2015, European Journal of Nuclear Medicine and Molecular Imaging CrossRef
  2. A Phase I Trial of Humanized Monoclonal Antibody A33 in Patients with Colorectal Carcinoma: Biodistribution, Pharmacokinetics, and Quantitative Tumor Uptake
    Andrew M. Scott et al, 2005, Clinical Cancer Research CrossRef
  3. The Evolution of Antibodies into Versatile Tumor-Targeting Agents
    Michael Z. Lin et al, 2005, Clinical Cancer Research CrossRef